Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03592186 · ClinicalTrials.gov registry record · NA

Adolescents With Substance Use Disorders Transitioníng From Residential Treatment to the Community

A NA study of Substance Use and Adolescent Behavior, sponsored by Brown University.

Completed
Registry status
NA
Development phase
122
Enrollment target
2
Study locations

NCT03592186 is a NA study of Substance Use and Adolescent Behavior that has completed, run by Brown University. The registered enrollment target is 122 participants, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03592186, a NA study of Substance Use and Adolescent Behavior, has completed, sponsored by Brown University.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target
2
Study locations

Study Summary

Adolescents with substance use disorders (ASUD) in residential treatment have the most serious substance use disorders and the highest rates of psychological, motivational, behavioral, legal, environmental, and vocational problems. ASUD in residential treatment are also at high risk of relapse, with follow-up studies suggesting that 60% of ASUD will relapse within 90 days of discharge. Parenting practices have been established as a key influence on adolescents' initiation and maintenance of substance use, as well as their substance use outcomes and likelihood of relapse. However, therapists who treat ASUD have reported a myriad of systemic barriers to engaging parents in treatment. Findings such as these deem ASUD in residential treatment a high priority population and argue for the value of easily accessible parenting interventions during this critical time. The proposed study evaluates a low cost, low intensity model for delivering parenting skills to parents preparing for their adolescent's discharge from residential substance use (SU) treatment. Specifically, this project involves adapting the delivery of a computerized parenting intervention (Parenting Wisely; PW) that has preliminary evidence of efficacy in improving parenting skills and reducing youth behavior problems. This study adapts the delivery of PW for a new population (parents of ASUD) and new setting (residential treatment), and obtains initial data on its feasibility, acceptability, and effectiveness. As a first step, an open trial with 10 parents was conducted to develop and pilot an adapted version of PW that included moderate engagement strategies: in-person coaching sessions, daily text messages containing reminders of parenting skills and links to video vignettes, and an online parent forum containing two networking boards (Ask an Expert and Connect with Parents). In the current phase, a pilot randomized trial with 60 parents will compare an adapted PW plus treatment as usual (TAU) condition (

Interventions

  • BEHAVIORAL Treatment as Usual
  • BEHAVIORAL Parenting Wisely+

Study Locations (2)

Illinois

  • Rosecrance Health Network - Rockford

Rhode Island

  • Caritas ARTS Program - Cranston

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2017-04-01
Est. Completion 2020-02-28
Phase NA

Sponsor

Brown University

231 total trials

What the Registry Record Tells You About NCT03592186

The ClinicalTrials.gov registry entry for NCT03592186 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (90% lower). The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT03592186 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT03592186 about?

NCT03592186 is a clinical study titled "Adolescents With Substance Use Disorders Transitioníng From Residential Treatment to the Community". Adolescents with substance use disorders (ASUD) in residential treatment have the most serious substance use disorders and the highest rates of psychological, motivational, behavioral, legal, environmental, and vocational problems. ASUD in residential treatment are also at high risk of relapse, with...

What is the current status of trial NCT03592186?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2017-04-01. Estimated completion is 2020-02-28.

What conditions does trial NCT03592186 study?

This clinical trial studies the following conditions: Substance Use, Adolescent Behavior.

What interventions are being tested in trial NCT03592186?

The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Parenting Wisely+ (BEHAVIORAL).

Who is sponsoring clinical trial NCT03592186?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03592186 being conducted?

This trial has 2 study locations across Illinois, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.